{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T11:26:22Z","timestamp":1743161182761},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The coexistence of primary hyperparathyroidism (PHPT) and giant toxic nodular goiter is very rare. Moreover, PHPT could be easily overlooked because hyperthyroidism may also lead to hypercalcemia. A 99mTc-MIBI scan of the parathyroid glands is often negative when they are concomitant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we report a rare case of the coexistence of giant toxic nodular goiter and PHPT that had been ignored for many years but was successfully treated with an ultrasound-guided parathyroid adenoma microwave ablation (MWA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Reoperation for PHPT carries an increased risk of cure failure and complications. Thermal ablation has been proven effective in inactivating hyperfunctioning parathyroid lesions and in normalizing both serum parathyroid hormone (PTH) and calcium.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01117-0","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:03:34Z","timestamp":1660043014000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: coexistence of primary hyperparathyroidism with giant toxic nodular goiter"],"prefix":"10.1186","volume":"22","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingtao","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"issue":"1","key":"1117_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/2047-783X-14-1-37","volume":"14","author":"O Heizmann","year":"2009","unstructured":"Heizmann O, Viehl CT, Schmid R, Muller-Brand J, Muller B, Oertli D. Impact of concomitant thyroid pathology on preoperative workup for primary hyperparathyroidism. Eur J Med Res. 2009;14(1):37\u201341.","journal-title":"Eur J Med Res"},{"issue":"5","key":"1117_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1245\/s10434-012-2286-6","volume":"19","author":"PM Spanheimer","year":"2012","unstructured":"Spanheimer PM, Weigel RJ. Management of patients with primary hyperparathyroidism and concurrent thyroid disease: an evolving field. Ann Surg Oncol. 2012;19(5):1428\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"1117_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1055\/s-0029-1212138","volume":"107","author":"B Wagner","year":"1999","unstructured":"Wagner B, Begic-Karup S, Raber W, Schneider B, Waldhausl W, Vierhapper H. Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium. Exp Clin Endocrinol Diabetes. 1999;107(7):457\u201361.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1117_CR4","doi-asserted-by":"publisher","first-page":"2182539","DOI":"10.1155\/2020\/2182539","volume":"2020","author":"E Castellano","year":"2020","unstructured":"Castellano E, Benso P, Attanasio R, Boriano A, Lauro C, Borretta G, et al. Surgical Approach to Primary Hyperparathyroidism in Patients with Concomitant Thyroid Diseases: A Retrospective Single Center Study. Int J Endocrinol. 2020;2020:2182539.","journal-title":"Int J Endocrinol"},{"issue":"4","key":"1117_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF03346819","volume":"14","author":"DM McGowan","year":"1991","unstructured":"McGowan DM, Vaswani A, Shperling I. Coexisting hyperparathyroidism with thyrotoxicosis. J Endocrinol Invest. 1991;14(4):305\u201310.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1117_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/hed.20366","volume":"28","author":"B Abboud","year":"2006","unstructured":"Abboud B, Sleilaty G, Mansour E, El Ghoul R, Tohme C, Noun R, et al. Prevalence and risk factors for primary hyperparathyroidism in hyperthyroid patients. Head Neck-J Sci Spec. 2006;28(5):420\u20136.","journal-title":"Head Neck-J Sci Spec"},{"key":"1117_CR7","doi-asserted-by":"crossref","first-page":"2050313X2110590","DOI":"10.1177\/2050313X211059002","volume":"9","author":"S Nagaki","year":"2021","unstructured":"Nagaki S, Tachikawa E, Kodama H, Obara T, Osawa M, Nagata S. A case of Turner\u2019s syndrome with Graves\u2019 disease and primary hyperparathyroidism. SAGE Open Med Case Rep. 2021;9:2050313X211059002.","journal-title":"SAGE Open Med Case Rep"},{"issue":"7","key":"1117_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2169\/internalmedicine.54.2605","volume":"54","author":"M Yokomoto","year":"2015","unstructured":"Yokomoto M, Minamoto M, Utsunomiya D, Umakoshi H, Fukuoka T, Kondo S. Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with Graves\u2019 disease. Intern Med. 2015;54(7):813\u20138.","journal-title":"Intern Med"},{"key":"1117_CR9","doi-asserted-by":"crossref","unstructured":"He Y, Liu S, Guo H, Shi B. Incidental finding of papillary thyroid carcinoma with BRAFV600E mutation in a patient with coexistent primary hyperparathyroidism and Graves' hyperthyroidism. BMJ Case Rep. 2014:bcr2013203436.","DOI":"10.1136\/bcr-2013-203436"},{"issue":"14","key":"1117_CR10","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2169\/internalmedicine.51.7102","volume":"51","author":"S Tachibana","year":"2012","unstructured":"Tachibana S, Sato S, Yokoi T, Nagaishi R, Akehi Y, Yanase T, et al. Severe hypocalcemia complicated by postsurgical hypoparathyroidism and hungry bone syndrome in a patient with primary hyperparathyroidism, Graves\u2019 disease, and acromegaly. Intern Med. 2012;51(14):1869\u201373.","journal-title":"Intern Med"},{"issue":"3","key":"1117_CR11","first-page":"199","volume":"23","author":"C Miani","year":"2003","unstructured":"Miani C, Bracale AM, Bresadola V, Motz E. Concomitant primary hyperparathyroidism, Graves\u2019 disease and vitamin D deficiency. Acta Otorhinolaryngol Ital. 2003;23(3):199\u2013202.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"6","key":"1117_CR12","first-page":"939","volume":"115","author":"H Xiao","year":"2002","unstructured":"Xiao H, Yu B, Wang S, Chen G. Concomitant Graves\u2019 disease and primary hyperparathyroidism: the first case report in mainland of China and literature review. Chin Med J (Engl). 2002;115(6):939\u201341.","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"1117_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF03344147","volume":"29","author":"M Losa","year":"2006","unstructured":"Losa M, Mortini P, Minelli R, Giovanelli M. Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism. J Endocrinol Invest. 2006;29(6):555\u20139.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1117_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1507\/endocrj.45.61","volume":"45","author":"Y Sato","year":"1998","unstructured":"Sato Y, Sakurai A, Miyamoto T, Hiramatsu K, Katai M, Furihata K, et al. Hyperfunctioning thyroid adenoma concomitant with papillary thyroid carcinoma, follicular thyroid adenoma and primary hyperparathyroidism. Endocr J. 1998;45(1):61\u20137.","journal-title":"Endocr J"},{"key":"1117_CR15","doi-asserted-by":"crossref","unstructured":"Vetshev PS, Zhivotov VA, Ablitsov AY, Drozhzhin AY, Sudilovskaya VV. [Combination of toxic multinodular goiter and primary hyperparathyroidism with rare ectopia of parathyroma]. Khirurgiia (Mosk). 2020;(1):89-93.","DOI":"10.17116\/hirurgia202001189"},{"issue":"2","key":"1117_CR16","first-page":"165","volume":"109","author":"P Bolko","year":"2003","unstructured":"Bolko P, Jaskula M, Wasko R, Bednarek J, Sowinski J. A rare coexistence of primary hyperparathyroidism and hyperthyroidism due to toxic nodular goiter\u2013a case report. Pol Arch Med Wewn. 2003;109(2):165\u20139.","journal-title":"Pol Arch Med Wewn"},{"key":"1117_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/CMED.S7116","volume":"4","author":"E Korytnaya","year":"2011","unstructured":"Korytnaya E, Rao NG, Mayrin JV. An unusual case of hypercalcemia associated with graves\u2019 disease and vitamin d deficiency. Clin Med Insights Endocrinol Diabetes. 2011;4:25\u20138.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"4","key":"1117_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.semnuclmed.2005.06.001","volume":"35","author":"CJ Palestro","year":"2005","unstructured":"Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35(4):266\u201376.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"1117_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00000658-200001000-00005","volume":"231","author":"JG Norman","year":"2000","unstructured":"Norman JG, Jaffray CE, Chheda H. The false-positive parathyroid sestamibi: a real or perceived problem and a case for radioguided parathyroidectomy. Ann Surg. 2000;231(1):31\u20137.","journal-title":"Ann Surg"},{"issue":"12","key":"1117_CR20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s12149-020-01520-4","volume":"34","author":"S Ishii","year":"2020","unstructured":"Ishii S, Sugawara S, Yaginuma Y, Kobiyama H, Hiruta M, Watanabe H, et al. Causes of false negatives in technetium-99 m methoxyisobutylisonitrile scintigraphy for hyperparathyroidism: influence of size and cysts in parathyroid lesions. Ann Nucl Med. 2020;34(12):892\u20138.","journal-title":"Ann Nucl Med"},{"issue":"2","key":"1117_CR21","first-page":"21n-2n","volume":"55","author":"SPECT\/CT and US in Hyperparathyroidism","year":"2014","unstructured":"SPECT\/CT and US in Hyperparathyroidism. J Nucl Med. 2014;55(2):21n-2n.","journal-title":"J Nucl Med"},{"issue":"9","key":"1117_CR22","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1210\/clinem\/dgab240","volume":"106","author":"Y Wei","year":"2021","unstructured":"Wei Y, Peng CZ, Wang SR, He JF, Peng LL, Zhao ZL, et al. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study. J Clin Endocrinol Metab. 2021;106(9):2707\u201317.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1117_CR23","first-page":"835","volume":"36","author":"F Liu","year":"2019","unstructured":"Liu F, Yu X, Liu Z, Qiao Z, Dou J, Cheng Z, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperthermia. 2019;36(1):835\u201340.","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"1117_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/UCD.2017.3369","volume":"33","author":"M Benkhadoura","year":"2017","unstructured":"Benkhadoura M, Taktuk S, Alobedi R. Recurrent laryngeal nerve injury and hypoparathyroidism rates in reoperative thyroid surgery. Turkish J Surg. 2017;33(1):14\u20138.","journal-title":"Turkish J Surg"},{"issue":"1","key":"1117_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00423-012-1004-y","volume":"398","author":"E Karakas","year":"2013","unstructured":"Karakas E, Muller HH, Schlosshauer T, Rothmund M, Bartsch DK. Reoperations for primary hyperparathyroidism-improvement of outcome over two decades. Langenbeck Arch Surg. 2013;398(1):99\u2013106.","journal-title":"Langenbeck Arch Surg"},{"issue":"10","key":"1117_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959\u201368.","journal-title":"JAMA Surg"},{"key":"1117_CR27","doi-asserted-by":"crossref","unstructured":"Marcocci C, Bollerslev J, Khan AA, Shoback DM. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2014;99(10):3607-18.","DOI":"10.1210\/jc.2014-1417"},{"issue":"6","key":"1117_CR28","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.surg.2011.09.017","volume":"150","author":"M Goldfarb","year":"2011","unstructured":"Goldfarb M, Gondek S, Irvin GL 3rd, Lew JI. Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years. Surgery. 2011;150(6):1076\u201384.","journal-title":"Surgery"},{"issue":"1","key":"1117_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jss.2007.06.009","volume":"143","author":"TD Beyer","year":"2007","unstructured":"Beyer TD, Chen EL, Nilubol N, Prinz RA, Solorzano CC. Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J Surg Res. 2007;143(1):145\u201350.","journal-title":"J Surg Res"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01117-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:05:33Z","timestamp":1660043133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01117-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1117"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01117-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"10 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written consent for their clinical details along with identifying images to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}